Abstract | OBJECTIVE: To evaluate the application of the immunohistochemistry (IHC) and the fluorescence in situ hybridization (FISH) in detecting the amplification and the expression of HER-2 gene in the breast cancer patients. METHODS: Sixty-six cases of paraffin-embeded breast cancer samples with overexpression, low or no expression of HER-2 gene as detected by IHC were analyzed for HER-2 gene amplification using FISH. RESULTS: Among the 42 samples with HER-2 gene overexpression (3+/2+) detected by IHC, 31 showed positive HER-2 gene amplification and 11 showed negative HER-2 gene amplification in FISH. In the 24 samples with low or no HER-2 gene expression (1+/-) detected by IHC, no HER-2 gene amplification was detected by FISH. The results of the two testing methods showed a good consistency with the kappa coefficient of 0.672 (P<0.001). We also found that the 17 chromosome polysomy in 42% of the samples and the incidence of 17 polysomy was significantly higher in the HER-2 gene overexpression (3+/2+) group than in low or no HER-2 gene expression (1+/-) group (chi(2)=4.688, P=0.03). CONCLUSION: IHC can be used as a screening method for detecting HER-2 gene amplification, and FISH should be performed in cases of HER-2 gene overexpression (3+/2+) as detected by IHC.
|
Authors | Xiao-Ying Pan, Hong-Yi Gao, Jia-Li Zhang, Wen-Ting Fu, Shu Liu |
Journal | Nan fang yi ke da xue xue bao = Journal of Southern Medical University
(Nan Fang Yi Ke Da Xue Xue Bao)
Vol. 29
Issue 11
Pg. 2225-7
(Nov 2009)
ISSN: 1673-4254 [Print] China |
PMID | 19923073
(Publication Type: Comparative Study, Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- ERBB2 protein, human
- Receptor, ErbB-2
|
Topics |
- Breast Neoplasms
(genetics, metabolism)
- Carcinoma, Ductal, Breast
(genetics, metabolism)
- Female
- Humans
- Immunohistochemistry
- In Situ Hybridization, Fluorescence
- Receptor, ErbB-2
(analysis, genetics)
|